nodes	percent_of_prediction	percent_of_DWPC	metapath
Codeine—UGT2B7—urinary bladder cancer	0.702	1	CbGaD
Codeine—UGT2B7—Epirubicin—urinary bladder cancer	0.0748	0.581	CbGbCtD
Codeine—CYP3A4—Thiotepa—urinary bladder cancer	0.0221	0.172	CbGbCtD
Codeine—CYP3A5—Etoposide—urinary bladder cancer	0.0154	0.119	CbGbCtD
Codeine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00642	0.0499	CbGbCtD
Codeine—CYP3A4—Etoposide—urinary bladder cancer	0.00599	0.0465	CbGbCtD
Codeine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00408	0.0317	CbGbCtD
Codeine—Ethylmorphine—POR—urinary bladder cancer	0.00262	0.656	CrCbGaD
Codeine—Morphine—UGT2B7—urinary bladder cancer	0.00138	0.344	CrCbGaD
Codeine—UGT2B7—prostate gland—urinary bladder cancer	0.00069	0.125	CbGeAlD
Codeine—OPRK1—prostate gland—urinary bladder cancer	0.000649	0.117	CbGeAlD
Codeine—CYP3A4—urine—urinary bladder cancer	0.000524	0.0948	CbGeAlD
Codeine—CYP2D6—urine—urinary bladder cancer	0.000516	0.0932	CbGeAlD
Codeine—UGT2B7—renal system—urinary bladder cancer	0.000471	0.0851	CbGeAlD
Codeine—OPRD1—renal system—urinary bladder cancer	0.000461	0.0834	CbGeAlD
Codeine—UGT2B7—female reproductive system—urinary bladder cancer	0.000377	0.0681	CbGeAlD
Codeine—OPRK1—female reproductive system—urinary bladder cancer	0.000354	0.0641	CbGeAlD
Codeine—SLC22A1—renal system—urinary bladder cancer	0.000281	0.0509	CbGeAlD
Codeine—CYP3A5—prostate gland—urinary bladder cancer	0.000251	0.0453	CbGeAlD
Codeine—SLC22A1—vagina—urinary bladder cancer	0.000204	0.0368	CbGeAlD
Codeine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000187	0.00206	CcSEcCtD
Codeine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000187	0.00206	CcSEcCtD
Codeine—Anorexia—Fluorouracil—urinary bladder cancer	0.000186	0.00206	CcSEcCtD
Codeine—Hypotension—Gemcitabine—urinary bladder cancer	0.000186	0.00205	CcSEcCtD
Codeine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000184	0.00203	CcSEcCtD
Codeine—Mood swings—Epirubicin—urinary bladder cancer	0.000183	0.00203	CcSEcCtD
Codeine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000183	0.00202	CcSEcCtD
Codeine—Hypotension—Fluorouracil—urinary bladder cancer	0.000183	0.00202	CcSEcCtD
Codeine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000182	0.00201	CcSEcCtD
Codeine—Tachycardia—Cisplatin—urinary bladder cancer	0.000181	0.002	CcSEcCtD
Codeine—Convulsion—Etoposide—urinary bladder cancer	0.00018	0.00199	CcSEcCtD
Codeine—Dehydration—Epirubicin—urinary bladder cancer	0.00018	0.00199	CcSEcCtD
Codeine—Insomnia—Gemcitabine—urinary bladder cancer	0.00018	0.00199	CcSEcCtD
Codeine—Diplopia—Doxorubicin—urinary bladder cancer	0.000179	0.00198	CcSEcCtD
Codeine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000179	0.00198	CcSEcCtD
Codeine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000177	0.00196	CcSEcCtD
Codeine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000177	0.00195	CcSEcCtD
Codeine—Insomnia—Fluorouracil—urinary bladder cancer	0.000177	0.00195	CcSEcCtD
Codeine—Somnolence—Gemcitabine—urinary bladder cancer	0.000177	0.00195	CcSEcCtD
Codeine—Anorexia—Cisplatin—urinary bladder cancer	0.000177	0.00195	CcSEcCtD
Codeine—Affect lability—Doxorubicin—urinary bladder cancer	0.000176	0.00195	CcSEcCtD
Codeine—Pancreatitis—Methotrexate—urinary bladder cancer	0.000175	0.00194	CcSEcCtD
Codeine—Discomfort—Etoposide—urinary bladder cancer	0.000175	0.00193	CcSEcCtD
Codeine—Breast disorder—Epirubicin—urinary bladder cancer	0.000175	0.00193	CcSEcCtD
Codeine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000174	0.00192	CcSEcCtD
Codeine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000174	0.00192	CcSEcCtD
Codeine—Somnolence—Fluorouracil—urinary bladder cancer	0.000174	0.00192	CcSEcCtD
Codeine—Hypotension—Cisplatin—urinary bladder cancer	0.000173	0.00191	CcSEcCtD
Codeine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000173	0.00191	CcSEcCtD
Codeine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000173	0.00191	CcSEcCtD
Codeine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000172	0.0019	CcSEcCtD
Codeine—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000171	0.00189	CcSEcCtD
Codeine—Fatigue—Gemcitabine—urinary bladder cancer	0.000171	0.00189	CcSEcCtD
Codeine—Confusional state—Etoposide—urinary bladder cancer	0.000171	0.00189	CcSEcCtD
Codeine—CYP3A5—renal system—urinary bladder cancer	0.000171	0.0309	CbGeAlD
Codeine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00017	0.00188	CcSEcCtD
Codeine—Constipation—Gemcitabine—urinary bladder cancer	0.00017	0.00188	CcSEcCtD
Codeine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00017	0.00188	CcSEcCtD
Codeine—Mood swings—Doxorubicin—urinary bladder cancer	0.00017	0.00187	CcSEcCtD
Codeine—Asthenia—Thiotepa—urinary bladder cancer	0.00017	0.00187	CcSEcCtD
Codeine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000169	0.00186	CcSEcCtD
Codeine—Pruritus—Thiotepa—urinary bladder cancer	0.000167	0.00185	CcSEcCtD
Codeine—Dehydration—Doxorubicin—urinary bladder cancer	0.000167	0.00184	CcSEcCtD
Codeine—Tachycardia—Etoposide—urinary bladder cancer	0.000166	0.00183	CcSEcCtD
Codeine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000165	0.00182	CcSEcCtD
Codeine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000164	0.00181	CcSEcCtD
Codeine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000164	0.00181	CcSEcCtD
Codeine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000164	0.00181	CcSEcCtD
Codeine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000164	0.00181	CcSEcCtD
Codeine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000162	0.00179	CcSEcCtD
Codeine—Anorexia—Etoposide—urinary bladder cancer	0.000162	0.00179	CcSEcCtD
Codeine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000161	0.00178	CcSEcCtD
Codeine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000161	0.00178	CcSEcCtD
Codeine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00016	0.00177	CcSEcCtD
Codeine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00016	0.00177	CcSEcCtD
Codeine—Drowsiness—Methotrexate—urinary bladder cancer	0.000159	0.00176	CcSEcCtD
Codeine—Depression—Methotrexate—urinary bladder cancer	0.000159	0.00176	CcSEcCtD
Codeine—Hypotension—Etoposide—urinary bladder cancer	0.000159	0.00175	CcSEcCtD
Codeine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000157	0.00174	CcSEcCtD
Codeine—Dizziness—Thiotepa—urinary bladder cancer	0.000156	0.00173	CcSEcCtD
Codeine—Urticaria—Fluorouracil—urinary bladder cancer	0.000155	0.00171	CcSEcCtD
Codeine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000154	0.00171	CcSEcCtD
Codeine—Sweating—Methotrexate—urinary bladder cancer	0.000153	0.00169	CcSEcCtD
Codeine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000153	0.00169	CcSEcCtD
Codeine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000152	0.00168	CcSEcCtD
Codeine—Dyspnoea—Etoposide—urinary bladder cancer	0.000151	0.00167	CcSEcCtD
Codeine—Somnolence—Etoposide—urinary bladder cancer	0.000151	0.00167	CcSEcCtD
Codeine—Vomiting—Thiotepa—urinary bladder cancer	0.00015	0.00166	CcSEcCtD
Codeine—Drowsiness—Epirubicin—urinary bladder cancer	0.000149	0.00165	CcSEcCtD
Codeine—Rash—Thiotepa—urinary bladder cancer	0.000149	0.00165	CcSEcCtD
Codeine—Dermatitis—Thiotepa—urinary bladder cancer	0.000149	0.00164	CcSEcCtD
Codeine—Decreased appetite—Etoposide—urinary bladder cancer	0.000148	0.00163	CcSEcCtD
Codeine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000147	0.00162	CcSEcCtD
Codeine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000146	0.00162	CcSEcCtD
Codeine—Fatigue—Etoposide—urinary bladder cancer	0.000146	0.00162	CcSEcCtD
Codeine—Constipation—Etoposide—urinary bladder cancer	0.000145	0.0016	CcSEcCtD
Codeine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000144	0.00159	CcSEcCtD
Codeine—Sweating—Epirubicin—urinary bladder cancer	0.000143	0.00158	CcSEcCtD
Codeine—Asthenia—Gemcitabine—urinary bladder cancer	0.000143	0.00158	CcSEcCtD
Codeine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000141	0.00156	CcSEcCtD
Codeine—Pruritus—Gemcitabine—urinary bladder cancer	0.000141	0.00155	CcSEcCtD
Codeine—Nausea—Thiotepa—urinary bladder cancer	0.00014	0.00155	CcSEcCtD
Codeine—Urethral disorder—Methotrexate—urinary bladder cancer	0.00014	0.00155	CcSEcCtD
Codeine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00014	0.00154	CcSEcCtD
Codeine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000139	0.00153	CcSEcCtD
Codeine—Pruritus—Fluorouracil—urinary bladder cancer	0.000138	0.00153	CcSEcCtD
Codeine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000138	0.00152	CcSEcCtD
Codeine—Visual impairment—Methotrexate—urinary bladder cancer	0.000138	0.00152	CcSEcCtD
Codeine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000136	0.00151	CcSEcCtD
Codeine—Bradycardia—Epirubicin—urinary bladder cancer	0.000136	0.00151	CcSEcCtD
Codeine—Urticaria—Etoposide—urinary bladder cancer	0.000135	0.00149	CcSEcCtD
Codeine—Body temperature increased—Etoposide—urinary bladder cancer	0.000134	0.00148	CcSEcCtD
Codeine—Abdominal pain—Etoposide—urinary bladder cancer	0.000134	0.00148	CcSEcCtD
Codeine—Eye disorder—Methotrexate—urinary bladder cancer	0.000134	0.00148	CcSEcCtD
Codeine—Asthenia—Cisplatin—urinary bladder cancer	0.000133	0.00147	CcSEcCtD
Codeine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000133	0.00147	CcSEcCtD
Codeine—Sweating—Doxorubicin—urinary bladder cancer	0.000132	0.00146	CcSEcCtD
Codeine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000132	0.00146	CcSEcCtD
Codeine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000131	0.00145	CcSEcCtD
Codeine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000129	0.00143	CcSEcCtD
Codeine—Dizziness—Fluorouracil—urinary bladder cancer	0.000129	0.00143	CcSEcCtD
Codeine—Visual impairment—Epirubicin—urinary bladder cancer	0.000129	0.00143	CcSEcCtD
Codeine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000129	0.00142	CcSEcCtD
Codeine—CYP3A4—renal system—urinary bladder cancer	0.000128	0.0232	CbGeAlD
Codeine—Vomiting—Gemcitabine—urinary bladder cancer	0.000126	0.0014	CcSEcCtD
Codeine—CYP2D6—renal system—urinary bladder cancer	0.000126	0.0228	CbGeAlD
Codeine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000126	0.00139	CcSEcCtD
Codeine—Rash—Gemcitabine—urinary bladder cancer	0.000125	0.00138	CcSEcCtD
Codeine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000125	0.00138	CcSEcCtD
Codeine—Eye disorder—Epirubicin—urinary bladder cancer	0.000125	0.00138	CcSEcCtD
Codeine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000125	0.00138	CcSEcCtD
Codeine—Erythema—Methotrexate—urinary bladder cancer	0.000125	0.00138	CcSEcCtD
Codeine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000124	0.00137	CcSEcCtD
Codeine—Flushing—Epirubicin—urinary bladder cancer	0.000124	0.00137	CcSEcCtD
Codeine—Vomiting—Fluorouracil—urinary bladder cancer	0.000124	0.00137	CcSEcCtD
Codeine—CYP3A5—vagina—urinary bladder cancer	0.000124	0.0224	CbGeAlD
Codeine—Rash—Fluorouracil—urinary bladder cancer	0.000123	0.00136	CcSEcCtD
Codeine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000123	0.00136	CcSEcCtD
Codeine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000122	0.00135	CcSEcCtD
Codeine—Asthenia—Etoposide—urinary bladder cancer	0.000122	0.00134	CcSEcCtD
Codeine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000121	0.00134	CcSEcCtD
Codeine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000121	0.00134	CcSEcCtD
Codeine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000121	0.00133	CcSEcCtD
Codeine—Pruritus—Etoposide—urinary bladder cancer	0.00012	0.00133	CcSEcCtD
Codeine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000119	0.00132	CcSEcCtD
Codeine—Nausea—Gemcitabine—urinary bladder cancer	0.000118	0.0013	CcSEcCtD
Codeine—Vomiting—Cisplatin—urinary bladder cancer	0.000118	0.0013	CcSEcCtD
Codeine—Rash—Cisplatin—urinary bladder cancer	0.000117	0.00129	CcSEcCtD
Codeine—Dermatitis—Cisplatin—urinary bladder cancer	0.000117	0.00129	CcSEcCtD
Codeine—Erythema—Epirubicin—urinary bladder cancer	0.000117	0.00129	CcSEcCtD
Codeine—Nausea—Fluorouracil—urinary bladder cancer	0.000116	0.00128	CcSEcCtD
Codeine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000116	0.00128	CcSEcCtD
Codeine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000116	0.00128	CcSEcCtD
Codeine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000115	0.00127	CcSEcCtD
Codeine—Flushing—Doxorubicin—urinary bladder cancer	0.000115	0.00127	CcSEcCtD
Codeine—Tension—Epirubicin—urinary bladder cancer	0.000114	0.00126	CcSEcCtD
Codeine—Nervousness—Epirubicin—urinary bladder cancer	0.000113	0.00125	CcSEcCtD
Codeine—Malaise—Methotrexate—urinary bladder cancer	0.000112	0.00124	CcSEcCtD
Codeine—Dizziness—Etoposide—urinary bladder cancer	0.000112	0.00124	CcSEcCtD
Codeine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000112	0.00124	CcSEcCtD
Codeine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000112	0.00124	CcSEcCtD
Codeine—Vertigo—Methotrexate—urinary bladder cancer	0.000112	0.00124	CcSEcCtD
Codeine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000112	0.00123	CcSEcCtD
Codeine—Nausea—Cisplatin—urinary bladder cancer	0.00011	0.00122	CcSEcCtD
Codeine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000108	0.00119	CcSEcCtD
Codeine—Convulsion—Methotrexate—urinary bladder cancer	0.000108	0.00119	CcSEcCtD
Codeine—Vomiting—Etoposide—urinary bladder cancer	0.000108	0.00119	CcSEcCtD
Codeine—Erythema—Doxorubicin—urinary bladder cancer	0.000108	0.00119	CcSEcCtD
Codeine—Agitation—Epirubicin—urinary bladder cancer	0.000107	0.00118	CcSEcCtD
Codeine—Rash—Etoposide—urinary bladder cancer	0.000107	0.00118	CcSEcCtD
Codeine—Dermatitis—Etoposide—urinary bladder cancer	0.000107	0.00118	CcSEcCtD
Codeine—Tension—Doxorubicin—urinary bladder cancer	0.000106	0.00117	CcSEcCtD
Codeine—Malaise—Epirubicin—urinary bladder cancer	0.000105	0.00116	CcSEcCtD
Codeine—Discomfort—Methotrexate—urinary bladder cancer	0.000105	0.00116	CcSEcCtD
Codeine—Nervousness—Doxorubicin—urinary bladder cancer	0.000105	0.00116	CcSEcCtD
Codeine—Vertigo—Epirubicin—urinary bladder cancer	0.000105	0.00116	CcSEcCtD
Codeine—Syncope—Epirubicin—urinary bladder cancer	0.000105	0.00115	CcSEcCtD
Codeine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000104	0.00115	CcSEcCtD
Codeine—Palpitations—Epirubicin—urinary bladder cancer	0.000103	0.00114	CcSEcCtD
Codeine—CYP3A4—female reproductive system—urinary bladder cancer	0.000103	0.0186	CbGeAlD
Codeine—Confusional state—Methotrexate—urinary bladder cancer	0.000102	0.00113	CcSEcCtD
Codeine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000102	0.00113	CcSEcCtD
Codeine—CYP2D6—female reproductive system—urinary bladder cancer	0.000101	0.0183	CbGeAlD
Codeine—Convulsion—Epirubicin—urinary bladder cancer	0.000101	0.00112	CcSEcCtD
Codeine—Nausea—Etoposide—urinary bladder cancer	0.000101	0.00111	CcSEcCtD
Codeine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.0001	0.00111	CcSEcCtD
Codeine—Nervous system disorder—Methotrexate—urinary bladder cancer	9.97e-05	0.0011	CcSEcCtD
Codeine—Agitation—Doxorubicin—urinary bladder cancer	9.91e-05	0.00109	CcSEcCtD
Codeine—Anxiety—Epirubicin—urinary bladder cancer	9.89e-05	0.00109	CcSEcCtD
Codeine—Hyperhidrosis—Methotrexate—urinary bladder cancer	9.83e-05	0.00109	CcSEcCtD
Codeine—Discomfort—Epirubicin—urinary bladder cancer	9.8e-05	0.00108	CcSEcCtD
Codeine—Malaise—Doxorubicin—urinary bladder cancer	9.73e-05	0.00107	CcSEcCtD
Codeine—Dry mouth—Epirubicin—urinary bladder cancer	9.71e-05	0.00107	CcSEcCtD
Codeine—Vertigo—Doxorubicin—urinary bladder cancer	9.69e-05	0.00107	CcSEcCtD
Codeine—Anorexia—Methotrexate—urinary bladder cancer	9.69e-05	0.00107	CcSEcCtD
Codeine—Syncope—Doxorubicin—urinary bladder cancer	9.67e-05	0.00107	CcSEcCtD
Codeine—Confusional state—Epirubicin—urinary bladder cancer	9.59e-05	0.00106	CcSEcCtD
Codeine—Palpitations—Doxorubicin—urinary bladder cancer	9.53e-05	0.00105	CcSEcCtD
Codeine—Hypotension—Methotrexate—urinary bladder cancer	9.5e-05	0.00105	CcSEcCtD
Codeine—Loss of consciousness—Doxorubicin—urinary bladder cancer	9.48e-05	0.00105	CcSEcCtD
Codeine—Shock—Epirubicin—urinary bladder cancer	9.36e-05	0.00103	CcSEcCtD
Codeine—Convulsion—Doxorubicin—urinary bladder cancer	9.34e-05	0.00103	CcSEcCtD
Codeine—Nervous system disorder—Epirubicin—urinary bladder cancer	9.33e-05	0.00103	CcSEcCtD
Codeine—Tachycardia—Epirubicin—urinary bladder cancer	9.28e-05	0.00103	CcSEcCtD
Codeine—Hyperhidrosis—Epirubicin—urinary bladder cancer	9.2e-05	0.00102	CcSEcCtD
Codeine—Insomnia—Methotrexate—urinary bladder cancer	9.19e-05	0.00102	CcSEcCtD
Codeine—Anxiety—Doxorubicin—urinary bladder cancer	9.15e-05	0.00101	CcSEcCtD
Codeine—Discomfort—Doxorubicin—urinary bladder cancer	9.07e-05	0.001	CcSEcCtD
Codeine—Anorexia—Epirubicin—urinary bladder cancer	9.07e-05	0.001	CcSEcCtD
Codeine—Dyspnoea—Methotrexate—urinary bladder cancer	9.06e-05	0.001	CcSEcCtD
Codeine—Somnolence—Methotrexate—urinary bladder cancer	9.04e-05	0.000998	CcSEcCtD
Codeine—Dry mouth—Doxorubicin—urinary bladder cancer	8.98e-05	0.000992	CcSEcCtD
Codeine—Hypotension—Epirubicin—urinary bladder cancer	8.89e-05	0.000982	CcSEcCtD
Codeine—Confusional state—Doxorubicin—urinary bladder cancer	8.88e-05	0.00098	CcSEcCtD
Codeine—Decreased appetite—Methotrexate—urinary bladder cancer	8.84e-05	0.000976	CcSEcCtD
Codeine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	8.78e-05	0.000969	CcSEcCtD
Codeine—Fatigue—Methotrexate—urinary bladder cancer	8.76e-05	0.000968	CcSEcCtD
Codeine—Shock—Doxorubicin—urinary bladder cancer	8.66e-05	0.000957	CcSEcCtD
Codeine—Nervous system disorder—Doxorubicin—urinary bladder cancer	8.63e-05	0.000954	CcSEcCtD
Codeine—Insomnia—Epirubicin—urinary bladder cancer	8.6e-05	0.00095	CcSEcCtD
Codeine—Tachycardia—Doxorubicin—urinary bladder cancer	8.59e-05	0.000949	CcSEcCtD
Codeine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	8.51e-05	0.00094	CcSEcCtD
Codeine—Dyspnoea—Epirubicin—urinary bladder cancer	8.48e-05	0.000937	CcSEcCtD
Codeine—Somnolence—Epirubicin—urinary bladder cancer	8.46e-05	0.000934	CcSEcCtD
Codeine—Anorexia—Doxorubicin—urinary bladder cancer	8.39e-05	0.000927	CcSEcCtD
Codeine—Feeling abnormal—Methotrexate—urinary bladder cancer	8.38e-05	0.000925	CcSEcCtD
Codeine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.31e-05	0.000918	CcSEcCtD
Codeine—Decreased appetite—Epirubicin—urinary bladder cancer	8.27e-05	0.000913	CcSEcCtD
Codeine—Hypotension—Doxorubicin—urinary bladder cancer	8.22e-05	0.000909	CcSEcCtD
Codeine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	8.21e-05	0.000907	CcSEcCtD
Codeine—Fatigue—Epirubicin—urinary bladder cancer	8.2e-05	0.000906	CcSEcCtD
Codeine—Constipation—Epirubicin—urinary bladder cancer	8.13e-05	0.000899	CcSEcCtD
Codeine—Urticaria—Methotrexate—urinary bladder cancer	8.08e-05	0.000892	CcSEcCtD
Codeine—Body temperature increased—Methotrexate—urinary bladder cancer	8.04e-05	0.000888	CcSEcCtD
Codeine—Abdominal pain—Methotrexate—urinary bladder cancer	8.04e-05	0.000888	CcSEcCtD
Codeine—Insomnia—Doxorubicin—urinary bladder cancer	7.96e-05	0.000879	CcSEcCtD
Codeine—Dyspnoea—Doxorubicin—urinary bladder cancer	7.85e-05	0.000867	CcSEcCtD
Codeine—Feeling abnormal—Epirubicin—urinary bladder cancer	7.84e-05	0.000866	CcSEcCtD
Codeine—Somnolence—Doxorubicin—urinary bladder cancer	7.83e-05	0.000864	CcSEcCtD
Codeine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.78e-05	0.000859	CcSEcCtD
Codeine—Decreased appetite—Doxorubicin—urinary bladder cancer	7.65e-05	0.000845	CcSEcCtD
Codeine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	7.6e-05	0.000839	CcSEcCtD
Codeine—Fatigue—Doxorubicin—urinary bladder cancer	7.59e-05	0.000838	CcSEcCtD
Codeine—Urticaria—Epirubicin—urinary bladder cancer	7.56e-05	0.000835	CcSEcCtD
Codeine—Constipation—Doxorubicin—urinary bladder cancer	7.53e-05	0.000831	CcSEcCtD
Codeine—Abdominal pain—Epirubicin—urinary bladder cancer	7.52e-05	0.000831	CcSEcCtD
Codeine—Body temperature increased—Epirubicin—urinary bladder cancer	7.52e-05	0.000831	CcSEcCtD
Codeine—Hypersensitivity—Methotrexate—urinary bladder cancer	7.49e-05	0.000827	CcSEcCtD
Codeine—Asthenia—Methotrexate—urinary bladder cancer	7.29e-05	0.000806	CcSEcCtD
Codeine—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.25e-05	0.000801	CcSEcCtD
Codeine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.2e-05	0.000795	CcSEcCtD
Codeine—Pruritus—Methotrexate—urinary bladder cancer	7.19e-05	0.000794	CcSEcCtD
Codeine—Hypersensitivity—Epirubicin—urinary bladder cancer	7.01e-05	0.000774	CcSEcCtD
Codeine—Urticaria—Doxorubicin—urinary bladder cancer	6.99e-05	0.000772	CcSEcCtD
Codeine—Body temperature increased—Doxorubicin—urinary bladder cancer	6.96e-05	0.000769	CcSEcCtD
Codeine—Abdominal pain—Doxorubicin—urinary bladder cancer	6.96e-05	0.000769	CcSEcCtD
Codeine—Asthenia—Epirubicin—urinary bladder cancer	6.83e-05	0.000754	CcSEcCtD
Codeine—Pruritus—Epirubicin—urinary bladder cancer	6.73e-05	0.000743	CcSEcCtD
Codeine—Dizziness—Methotrexate—urinary bladder cancer	6.72e-05	0.000743	CcSEcCtD
Codeine—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.49e-05	0.000716	CcSEcCtD
Codeine—Vomiting—Methotrexate—urinary bladder cancer	6.46e-05	0.000714	CcSEcCtD
Codeine—Rash—Methotrexate—urinary bladder cancer	6.41e-05	0.000708	CcSEcCtD
Codeine—Dermatitis—Methotrexate—urinary bladder cancer	6.4e-05	0.000707	CcSEcCtD
Codeine—Asthenia—Doxorubicin—urinary bladder cancer	6.32e-05	0.000698	CcSEcCtD
Codeine—Dizziness—Epirubicin—urinary bladder cancer	6.29e-05	0.000695	CcSEcCtD
Codeine—Pruritus—Doxorubicin—urinary bladder cancer	6.23e-05	0.000688	CcSEcCtD
Codeine—Vomiting—Epirubicin—urinary bladder cancer	6.05e-05	0.000668	CcSEcCtD
Codeine—Nausea—Methotrexate—urinary bladder cancer	6.04e-05	0.000667	CcSEcCtD
Codeine—Rash—Epirubicin—urinary bladder cancer	6e-05	0.000663	CcSEcCtD
Codeine—Dermatitis—Epirubicin—urinary bladder cancer	5.99e-05	0.000662	CcSEcCtD
Codeine—Dizziness—Doxorubicin—urinary bladder cancer	5.82e-05	0.000643	CcSEcCtD
Codeine—Nausea—Epirubicin—urinary bladder cancer	5.65e-05	0.000624	CcSEcCtD
Codeine—Vomiting—Doxorubicin—urinary bladder cancer	5.6e-05	0.000618	CcSEcCtD
Codeine—Rash—Doxorubicin—urinary bladder cancer	5.55e-05	0.000613	CcSEcCtD
Codeine—Dermatitis—Doxorubicin—urinary bladder cancer	5.54e-05	0.000612	CcSEcCtD
Codeine—Nausea—Doxorubicin—urinary bladder cancer	5.23e-05	0.000578	CcSEcCtD
Codeine—OPRK1—Signaling Pathways—GLI1—urinary bladder cancer	3.31e-05	0.000476	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—RRM2—urinary bladder cancer	3.29e-05	0.000473	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	3.14e-05	0.000452	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—HPGDS—urinary bladder cancer	3.05e-05	0.000438	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—ENO2—urinary bladder cancer	3.05e-05	0.000438	CbGpPWpGaD
Codeine—OPRD1—GPCR ligand binding—CXCL8—urinary bladder cancer	3.04e-05	0.000438	CbGpPWpGaD
Codeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	2.96e-05	0.000426	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PPARG—urinary bladder cancer	2.96e-05	0.000426	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GSTT1—urinary bladder cancer	2.95e-05	0.000425	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—TYMP—urinary bladder cancer	2.88e-05	0.000414	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—CREBBP—urinary bladder cancer	2.84e-05	0.000409	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	2.83e-05	0.000407	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—GLI1—urinary bladder cancer	2.8e-05	0.000403	CbGpPWpGaD
Codeine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.75e-05	0.000395	CbGpPWpGaD
Codeine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.71e-05	0.00039	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—TYMP—urinary bladder cancer	2.68e-05	0.000385	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	2.67e-05	0.000384	CbGpPWpGaD
Codeine—OPRK1—GPCR ligand binding—CXCL8—urinary bladder cancer	2.67e-05	0.000384	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	2.6e-05	0.000374	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	2.6e-05	0.000374	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—RBX1—urinary bladder cancer	2.59e-05	0.000372	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	2.58e-05	0.000371	CbGpPWpGaD
Codeine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.53e-05	0.000363	CbGpPWpGaD
Codeine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.49e-05	0.000358	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—NQO1—urinary bladder cancer	2.46e-05	0.000353	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	2.44e-05	0.000351	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	2.44e-05	0.000351	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TSC1—urinary bladder cancer	2.43e-05	0.00035	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—NAT2—urinary bladder cancer	2.42e-05	0.000348	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PTGS2—urinary bladder cancer	2.33e-05	0.000335	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—JAG1—urinary bladder cancer	2.32e-05	0.000333	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—RBX1—urinary bladder cancer	2.27e-05	0.000326	CbGpPWpGaD
Codeine—OPRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	2.26e-05	0.000324	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	2.25e-05	0.000323	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	2.23e-05	0.000321	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TSC1—urinary bladder cancer	2.13e-05	0.000307	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—RRM2—urinary bladder cancer	2.09e-05	0.000301	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	2.08e-05	0.000299	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	2.08e-05	0.000299	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.08e-05	0.000299	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	2.05e-05	0.000294	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—JAG1—urinary bladder cancer	2.03e-05	0.000292	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—PTEN—urinary bladder cancer	2.03e-05	0.000292	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.02e-05	0.00029	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.01e-05	0.000289	CbGpPWpGaD
Codeine—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	1.99e-05	0.000286	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.96e-05	0.000282	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—ENO2—urinary bladder cancer	1.94e-05	0.000279	CbGpPWpGaD
Codeine—UGT2B4—Metabolism—EP300—urinary bladder cancer	1.94e-05	0.000279	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	1.94e-05	0.000279	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	1.92e-05	0.000276	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.9e-05	0.000274	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.9e-05	0.000273	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.88e-05	0.000271	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.88e-05	0.000271	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.88e-05	0.000271	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	1.88e-05	0.00027	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—S100B—urinary bladder cancer	1.88e-05	0.00027	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.85e-05	0.000266	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	1.8e-05	0.000259	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.8e-05	0.000259	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—RHOA—urinary bladder cancer	1.78e-05	0.000256	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.77e-05	0.000254	CbGpPWpGaD
Codeine—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.76e-05	0.000253	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.72e-05	0.000247	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.72e-05	0.000247	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	1.72e-05	0.000247	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—NCOR1—urinary bladder cancer	1.69e-05	0.000243	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.68e-05	0.000242	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	1.68e-05	0.000241	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	0.000239	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	1.65e-05	0.000237	CbGpPWpGaD
Codeine—OPRD1—GPCR downstream signaling—IL2—urinary bladder cancer	1.64e-05	0.000236	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.62e-05	0.000234	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.6e-05	0.00023	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.6e-05	0.00023	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.56e-05	0.000225	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—NQO1—urinary bladder cancer	1.56e-05	0.000225	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	1.56e-05	0.000224	CbGpPWpGaD
Codeine—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	1.53e-05	0.000219	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.51e-05	0.000217	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.5e-05	0.000216	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.5e-05	0.000216	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—IL2—urinary bladder cancer	1.49e-05	0.000215	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TERT—urinary bladder cancer	1.49e-05	0.000214	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.48e-05	0.000213	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	1.48e-05	0.000213	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.46e-05	0.00021	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.46e-05	0.00021	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.45e-05	0.000209	CbGpPWpGaD
Codeine—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	1.44e-05	0.000207	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.4e-05	0.000201	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	1.39e-05	0.0002	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.37e-05	0.000197	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—FGFR3—urinary bladder cancer	1.36e-05	0.000196	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PPARG—urinary bladder cancer	1.35e-05	0.000194	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.34e-05	0.000192	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ESR1—urinary bladder cancer	1.33e-05	0.000191	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	1.32e-05	0.00019	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.32e-05	0.000189	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	1.31e-05	0.000188	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	1.3e-05	0.000187	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	1.3e-05	0.000187	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.3e-05	0.000187	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	1.3e-05	0.000186	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	0.000185	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	0.000185	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.27e-05	0.000183	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	1.25e-05	0.00018	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.24e-05	0.000179	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.23e-05	0.000177	CbGpPWpGaD
Codeine—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	1.22e-05	0.000175	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.21e-05	0.000174	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.21e-05	0.000174	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.21e-05	0.000174	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.21e-05	0.000174	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	0.000172	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	0.000172	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	1.2e-05	0.000172	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	1.16e-05	0.000167	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CREBBP—urinary bladder cancer	1.16e-05	0.000167	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.16e-05	0.000166	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.16e-05	0.000166	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IGF1—urinary bladder cancer	1.15e-05	0.000165	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.15e-05	0.000165	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—EGFR—urinary bladder cancer	1.14e-05	0.000164	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	0.000163	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	0.000162	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	1.11e-05	0.000159	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	1.1e-05	0.000158	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—KRAS—urinary bladder cancer	1.08e-05	0.000155	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.07e-05	0.000154	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.07e-05	0.000154	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	0.000153	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	0.000152	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—RHOA—urinary bladder cancer	1.05e-05	0.000151	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.04e-05	0.000149	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	1.02e-05	0.000146	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.01e-05	0.000145	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	1.01e-05	0.000145	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	1.01e-05	0.000145	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	1e-05	0.000144	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	9.82e-06	0.000141	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—ERBB2—urinary bladder cancer	9.73e-06	0.00014	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	9.68e-06	0.000139	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	9.45e-06	0.000136	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	9.4e-06	0.000135	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	9.3e-06	0.000134	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	9.3e-06	0.000134	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—PTEN—urinary bladder cancer	9.25e-06	0.000133	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CXCL8—urinary bladder cancer	9.22e-06	0.000133	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	9.22e-06	0.000133	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	9.21e-06	0.000133	CbGpPWpGaD
Codeine—OPRD1—Signaling by GPCR—HRAS—urinary bladder cancer	9.16e-06	0.000132	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	8.9e-06	0.000128	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	8.85e-06	0.000127	CbGpPWpGaD
Codeine—UGT2B7—Metabolism—EP300—urinary bladder cancer	8.82e-06	0.000127	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—IL2—urinary bladder cancer	8.82e-06	0.000127	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	8.75e-06	0.000126	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	8.74e-06	0.000126	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.62e-06	0.000124	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	8.61e-06	0.000124	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CCND1—urinary bladder cancer	8.59e-06	0.000124	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	8.58e-06	0.000123	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	8.53e-06	0.000123	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	8.5e-06	0.000122	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	8.46e-06	0.000122	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MMP9—urinary bladder cancer	8.34e-06	0.00012	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.31e-06	0.00012	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—PTEN—urinary bladder cancer	8.29e-06	0.000119	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	8.24e-06	0.000118	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	8.22e-06	0.000118	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	8.09e-06	0.000116	CbGpPWpGaD
Codeine—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	8.04e-06	0.000116	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	7.99e-06	0.000115	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—EP300—urinary bladder cancer	7.91e-06	0.000114	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	7.79e-06	0.000112	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	7.73e-06	0.000111	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—SRC—urinary bladder cancer	7.69e-06	0.000111	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.55e-06	0.000109	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	7.54e-06	0.000108	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	7.32e-06	0.000105	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.29e-06	0.000105	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	7.27e-06	0.000105	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	7.25e-06	0.000104	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	7.21e-06	0.000104	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7.19e-06	0.000103	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7e-06	0.000101	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7e-06	0.000101	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	6.94e-06	9.98e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—MYC—urinary bladder cancer	6.89e-06	9.91e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	6.84e-06	9.83e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	6.79e-06	9.77e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6.79e-06	9.76e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	6.75e-06	9.7e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	6.75e-06	9.7e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—EGFR—urinary bladder cancer	6.74e-06	9.7e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.69e-06	9.62e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	6.66e-06	9.58e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.61e-06	9.51e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.61e-06	9.51e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	6.53e-06	9.4e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	6.4e-06	9.2e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—KRAS—urinary bladder cancer	6.37e-06	9.16e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	6.37e-06	9.16e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.33e-06	9.1e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	6.32e-06	9.09e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.22e-06	8.94e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	6.18e-06	8.89e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.16e-06	8.86e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	6.15e-06	8.84e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	6.04e-06	8.69e-05	CbGpPWpGaD
Codeine—CYP3A7—Metabolism—EP300—urinary bladder cancer	6.03e-06	8.67e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	5.91e-06	8.5e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	5.88e-06	8.46e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	5.86e-06	8.43e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.84e-06	8.4e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	5.7e-06	8.2e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—TP53—urinary bladder cancer	5.66e-06	8.14e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.64e-06	8.11e-05	CbGpPWpGaD
Codeine—SLC22A1—Metabolism—EP300—urinary bladder cancer	5.61e-06	8.07e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	5.59e-06	8.03e-05	CbGpPWpGaD
Codeine—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	5.41e-06	7.79e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.24e-06	7.54e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	5.11e-06	7.35e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	5e-06	7.19e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	4.96e-06	7.14e-05	CbGpPWpGaD
Codeine—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	4.75e-06	6.83e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.74e-06	6.81e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	4.72e-06	6.79e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.7e-06	6.76e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	4.57e-06	6.57e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.55e-06	6.54e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.37e-06	6.29e-05	CbGpPWpGaD
Codeine—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.36e-06	6.27e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.32e-06	6.22e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.32e-06	6.22e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	4.2e-06	6.03e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.14e-06	5.95e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.06e-06	5.84e-05	CbGpPWpGaD
Codeine—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	4.01e-06	5.77e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.82e-06	5.49e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.73e-06	5.36e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.25e-06	4.67e-05	CbGpPWpGaD
Codeine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.1e-06	4.46e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.1e-06	4.45e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.98e-06	4.28e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.44e-06	3.5e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.12e-06	3.06e-05	CbGpPWpGaD
Codeine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.03e-06	2.91e-05	CbGpPWpGaD
